Mucosal leishmaniasis unresponsive to glucantime therapy successfully treated with AmBisome(TM)

被引:11
作者
Sampaio, RNR
Marsden, PD
机构
[1] Laboratory of Dermatomycology, University of Brasilia, Brasilia
[2] Depto. de Clinica Médica, Universidade de Brasilia, Campus Universitário, Brasilia, DF
关键词
leishmaniasis; Leishmania braziliensis; chemotherapy; AmBisome(TM);
D O I
10.1016/S0035-9203(97)90404-1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
[No abstract available]
引用
收藏
页码:77 / 77
页数:1
相关论文
共 5 条
[1]   LIPOSOMAL AMPHOTERICIN-B IN DRUG-RESISTANT VISCERAL LEISHMANIASIS [J].
DAVIDSON, RN ;
CROFT, SL ;
SCOTT, A ;
MAINI, M ;
MOODY, AH ;
BRYCESON, ADM .
LANCET, 1991, 337 (8749) :1061-1062
[2]   DRUG-RESISTANCE IN LEISHMANIASIS - ITS IMPLICATION IN SYSTEMIC CHEMOTHERAPY OF CUTANEOUS AND MUCOCUTANEOUS DISEASE [J].
GROGL, M ;
THOMASON, TN ;
FRANKE, ED .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1992, 47 (01) :117-126
[4]  
Sampaio R N, 1985, Lancet, V1, P1097
[5]   Comparison of three treatment regimens with liposomal amphotericin B (AmBisome(R)) for visceral leishmaniasis in India: A randomized dose-finding study [J].
Thakur, CP ;
Pandey, AK ;
Sinha, GP ;
Roy, S ;
Behbehani, K ;
Olliaro, P .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1996, 90 (03) :319-322